Sort
48,018 grants matching “immunotherapy”
ECOG-ACRIN Thoracic Malignancies Integrated Translational Science Center
$852,400Suresh S Ramalingam · Emory University · UG1 · FY2019 · CA
ApoVax104-HPV as a Novel Vaccine for Cervical Cancer
$852,358Kathryn J. Macleod · Apovax, Inc. · R44 · FY2009 · AI
Development and Function of NKT Cells
$852,188Mitchell Kronenberg · La Jolla Institute For Immunology · R37 · FY2012 · AI
Bispecific Antibody Therapeutics for Neuroblastoma and Diffuse Midline Glioma
$851,913James M Olson · Seattle Children'S Hospital · U01 · FY2025 · CA
A Data Resource for Blood and Marrow Transplants and Adoptive Cellular Therapy Research
$851,816Bronwen Shaw · Medical College Of Wisconsin · U24 · FY2025 · CA
TRAF6 Nanoimmunotherapy to resolve plaque inflammation
$851,576Willem Mulder · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · HL
THE CANCER EPITOPE DATABASE AND ANALYSIS RESOURCE
$851,522Alessandro Sette · La Jolla Institute For Immunology · U24 · FY2025 · CA
Receptor Mediated T and B Cell Activation
$851,361Richard J. Hodes · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA
CARE Network - Tucson Clinical Center
$851,199University Of Arizona · U10 · FY2004 · HL
Clinical Protocoal and Data Management
$851,107Carrie B Lee · Univ Of North Carolina Chapel Hill · P30 · FY2023 · CA
Clinical Protocoal and Data Management
$851,107Carrie B Lee · Univ Of North Carolina Chapel Hill · P30 · FY2021 · CA
Clinical Protocoal and Data Management
$851,107Carrie B Lee · Univ Of North Carolina Chapel Hill · P30 · FY2022 · CA
Proteogenomic translator for cancer biomarker discovery towards precision medicine
$850,957Pei Wang · Icahn School Of Medicine At Mount Sinai · U24 · FY2022 · CA
ULTRASOUND-GUIDED TARGETED STING ACTIVATION FOR BREAST CANCER IMMUNOTHERAPY
$850,500The Univeristy Of Texas M.D. Anderson Cancer Center · · FY2021 · Defense Health Agency
Basic Research Support for the CCR
$850,265Robert Wiltrout · Division Of Basic Sciences - Nci · ZIC · FY2013 · CA
Process Development and Preclinical Advancement of a Novel Nanoparticle Formulation for Immune Activation
$850,188Richard Johnson · Saros Therapeutics Inc · R44 · FY2024 · CA
Engineering Effective T cell Immunity to Multiple Myeloma
$850,024Stanley R Riddell · Fred Hutchinson Cancer Center · P01 · FY2024 · CA
Engineering Effective T cell Immunity to Multiple Myeloma
$850,024Stanley R Riddell · Fred Hutchinson Cancer Center · P01 · FY2025 · CA
Transformable Theranostics for imaging-guided interventions in head and neck squamous cell carcinoma
$849,788Tzu-Yin Lin · Theranostec, Inc. · R44 · FY2023 · CA
Recombinant Interleukin-12 for Cutaneous T-Cell Lymphoma
$849,362University Of Pennsylvania · R01 · FY2003 · CA
Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck Cancers
$849,319Stephen Philip Schoenberger · La Jolla Institute For Immunology · U01 · FY2021 · DE
Enhancing Cancer Immunotherapy: Targeting the Tumor and Targeting the Host
$849,297Ronald Levy · Stanford University · R35 · FY2021 · CA
Immunotherapy for Malignant Mesothelioma, Lung Cancer and Thymic Malignancies
$849,274Raffit Hassan · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Targeting PD-1 Pathway for Functional Cure of AIDS
$849,204Rama Rao Amara · Emory University · R37 · FY2021 · AI
Hepatitis C: Studies of Immunity and Pathogenesis
$848,905Rockefeller University · U19 · FY2005 · AI